Idiopathic inflammatory myopathies

Journal of Association of Physicians of India

Volumn 54, Issue SUPL., 2006, Pages 62-66

  Kumar, Ashok ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MYOSITIS; REVIEW;

HUMANS; MYOSITIS;

EID: 33750586363     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Dalakas MC. Polymyositis. dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
2. Bunch TW. Worthington JW. Combs JJ. IIstrup DM. Engel AG. Azathioprine with prednisone for polymyositis. Ann Intern Med 1980:92:365-9.
3. Kroll M, Otis J, Kagen L. Serum enzyme myoglobin and muscle strength relationships in polymyositis and dermatomyositis. J Rheumatol 1986:13:349-55.
4. Lundberg I, Kartz A-K, Nennesmo I, Andersson U, Klareskog L. Effects of corticosteroid treatment on IL-1 and ILβ expression in muscle tissue in patients with inflammatory myopathies. Arthritis Rheum 1997;40S180.
5. Newman ED, Kurland RJ. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Arthritis Rheum 1992;35:199-203.
6. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL. Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.
7. Chung YL, Smith EC, Williams SCR, et al. In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: A preliminary study. Eur J Med Res 1997:2:483-7.
8. Bohan A, Peter JB, Polymyositis and dermatomyositis: First of two parts. N Engl J Med 1975;292:344-47.
9. Wortmann RL. Inflammatory diseases of the muscle and other myopathies. In : Kelley WN. Harris ED Jr. Ruddy S. Sledgc CB (Eds): Textbook of Rheumatology. 5th Edition. Philadelphia. WB Saunders 1996.
10. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994;20:857-80.
11. Seth V, Kabra SK, Semwal OP, Jain Y. Juvenile dermatomyositis. Indian J Pediatr 1996;63:375-9.
12. Singh S, Kumar L, Shankar KR. Juvenile dermatomyositis in north India.Indian Pediatr 1997;34:193-8.
13. Prasad ML, Sarkar C, Roy S, et al. Idiopathic inflammatory myopathy: clinico-pathological observations in the Indian population. Brit J Rheumatol 1992;31:835-39.
14. Chowdhary V, Aggarwal A, Misra R. Prevalence and clinical association of myositis-specific autoantibodies in North Indian patients with idiopathic inflammatory myopathy. APLAR J Rheumatol 2001.
15. Love LA. LefTRL, Frascr DD, et al. A new approach to classification of idiopathic inflammation myopathies: Myositis-specific autoantibodies define useful homogeneous patients groups. Medicine (Baltimore) 1991;70:360-74.
16. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al Clinical, serologic and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:1257-66.
17. Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-23.
18. Daniels L, Worthingham C. Muscle testing. 4th edn. Philadelphia: WB Saunders. 1972. Helewa A. Goldsmith CH. Smythe HA. The modified sphygmomanometer - An instrument to measure muscle strength: A validation study. J Chron Dis 1981;34:353-61.
19. Stroll T, Brühlmann P, Stucki G, Seifert B, Michel BA. Muscle strength assessment in polymyositis and dermatomyositis: evaluation of the reliability and clinical use of a new, quantitative, easily applicable method. J Rheumatol 1995;22:473-7.
20. Csuka M. McCarty DJ. Simple method for measurement of lower extremity muscle strength. Am J Med 1985;78:77-81.
21. Josefson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996;23:1380-4.
22. Barwick DD, Walton JN. Polymyositis Am J Med 1963;35:646-60.
23. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. Am J Med 1986;80:329-32.
24. Adams EM. Plotz PH. The treatment of myositis. Rheum Dis Clin North Am 1995;21:179-97.
25. Rose AL, Walton JN, Polymyositis: A survey of cases with particular reference to treatment and prognosis. Brain 1966;89:747-68.
26. Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;86:255-86.
27. Noakes TD. Effect of exercise in serum enzymes activities in humans. Sports Med 1987;4:245-67.
28. Lundberg IE, Dorph C, Nennesmol. Percutaneous conchotome technique - A valuable and safe procedure for muscle biopsies. Arthritis Rheum 1998;1024:S203.
29. Fraser DD, Frank JA, Dalakas Miller FW, Ricks JE, Plotz P. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
30. Reimers CD, Schedel H, Fleckenstein JL, et al. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994;241:306-14.
31. Kaufman LD, Gruber BL, Gerstman DP, Kaell AT. Preliminary observation on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheumatol Dis 1987;46:569-72.
32. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL. Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.
33. Kaufman LD, Gruber BL, Gerstman DP, Kaell AT. Preliminary observation on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheumatol Dis 1987;46:569-72.
34. Kari S, Olsen NJ, Park JH. Evaluation of muscle diseases using artificial neural network analysis of 31P MR spectroscopy data. Magn Reson Med 1995;34:664-72.
35. Chung YL. Wassif WS. Bell D, et al. Urinary assessment of disease activity in polymyositis by in vitro NMR Proceedings of the International Society for Magnetic Resonance in Medicine 1996;2:1091.
36. Lundberg I, Chung YL. Treatment and investigation of idiopathic inflammatory myopathies. Rheumatology 2000;39:7-17.
37. Rose AL, Walton JN. Polymyositis: A survey of 89 cases with particular reference to treatment and prognosis. Brain 1966;89:747-68.
38. Vignos PJ, Bowling GF, Watkins MP. Polymyositis Arch Intern Med 1964;114:263-77.
39. . Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;86:255-86.
40. Henriksson KG, Lindvall B. Polymyositis and dermatomyositis 1990 - diagnosis, treatment and prognosis. Prog Neurobiol 1990;35:181-93.
41. Henriksson KG, Sandstedt P. Polymyositis - treatment and prognosis. Acta Ncurol Scand 1982;65:280-300.
42. Bunch TW. Prednisone and azathioprine for polymyositis. Arthritis Rheum 1981:24:45-8.
43. Villalba L, Hicks JE, Adams EM et al. Treatment of refractory myositis. Arthritis Rheum 1998:41:392-9.
44. Dalakas MC, Illa I, Dambrosia JM et al. A controlled trial of highdose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
45. Miller FW, Leitman SF, Cronia ME. Controlled trial of plasma exchange and leucapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-4.
46. Malaviya AN, Many R, Schunong RS. Treatment of dermatomyositis with methotrexate. Lancet 1968;2:485-8.
47. Metzgcr AL, Bohan A, Goldberg LS, Bluestonc R, Pearson CM. Polymyositis and dermatomyositis: Combined methotrexate and corticosteroid therapy. Ann Intern Med 1974;81:182-9.
48. Adams EM, Plotz PH. The treatment of myositis. Rheum Dis Clin North Am 1995;21:179-97.
49. Alexanderson H, Stenstrom C, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology 1999;38:608-11.
50. Wiesinger GF, Quittan M, Aringer M, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998;37:196-200.
51. Hicks JE. Role of rehabilitation in the management of myopathies. Curr Opin Rheumatol 1998;10:548-55.
52. Henriksson KG, Sandstedt P. Polymyositis - treatment and prognosis. Acta Neurol Scand 1982;65:280-300.
53. Thymms KE, Webb J. Dermatomyositis and other connective tissue diseases. A review of 105 cases. J Rheumatol 1985;12:1140-8.